Pilot study: Biomarkers for diagnosis of neutrophil inflammatory/ allergic asthma

Pilot study: Biomarkers for diagnosis of neutrophil inflammatory/ allergic asthma - Pilot study: Biomarkers for neutrophil inflammatory/ allergic asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43341

Enrollment

Registered

2016-04-05

Start date

2016-06-02

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Severe) asthma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy controls

Exclusion criteria

Exclusion criteria: -People with asthma -People suffering form other (chronic, pulmonary or autoimmune) diseases than asthma -People that had an infection within two weeks prior to investigation -People having immunodeficiency -People who take steroids, antibiotics or probiotics

Design outcomes

Secondary

Measure	Time frame
-	—

Primary

Measure	Time frame
Th1/Th2/Th17 patterns in the nasal lavage, saliva and blood of healthy controls by measuring cytokine levels.	—

Countries

Netherlands

Outcome results